These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6526155)

  • 1. Experiences in the production of human monoclonal antibodies to tetanus toxoid.
    Boyd JE; Hastings I; Farzad Z; James K; McClelland DB
    Dev Biol Stand; 1984; 57():93-8. PubMed ID: 6526155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A human monoclonal antibody specific for tetanus toxoid.
    Olsson L; Mazauric T; Vincent-Falquet JC; Armand J
    Dev Biol Stand; 1984; 57():87-91. PubMed ID: 6526153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
    Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
    Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyspecific human and murine antibodies to diphtheria and tetanus toxoids and phospholipids.
    Sutjita M; Hohmann A; Comacchio R; Bradley J
    Clin Exp Immunol; 1988 Aug; 73(2):191-7. PubMed ID: 3263226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro immunization for the production of antibodies to tetanus toxin and toxoid. 2. Antibody production in lymphocyte cultures].
    Jahn S; Kiessig ST; Grunow R; von Baehr R
    Allerg Immunol (Leipz); 1987; 33(2):89-94. PubMed ID: 2959130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies in the development of human monoclonal antibodies.
    Jahn S; Grunow R; Kiessig ST; Settmacher U; Von Baehr R
    Dev Biol Stand; 1990; 71():3-7. PubMed ID: 2401386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human hybrid hybridoma.
    Tiebout RF; van Boxtel-Oosterhof F; Stricker EA; Zeijlemaker WP
    J Immunol; 1987 Nov; 139(10):3402-5. PubMed ID: 3119707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducible production of protective human monoclonal antibodies by fusion of peripheral blood lymphocytes with a mouse myeloma cell line.
    Gigliotti F; Smith L; Insel RA
    J Infect Dis; 1984 Jan; 149(1):43-7. PubMed ID: 6607295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of specific human mab's by a small scale electrofusion technique: the influence of some physical and chemical factors on hybridoma yield of human peripheral blood lymphocytes XCB-F7 fusions.
    Glaser RW; Jahn S; Grunow R
    Allerg Immunol (Leipz); 1989; 35(2):123-32. PubMed ID: 2788981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single human monoclonal antibody that confers total protection from tetanus.
    Arunachalam B; Ghosh S; Talwar GP; Raghupathy R
    Hybridoma; 1992 Apr; 11(2):165-79. PubMed ID: 1376715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
    Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
    Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of specific IgG-producing human hybridomas by fusions of lymphocytes from actively immunized persons.
    Jahn S; Settmacher U; Haensel K; Kiessig S; Grunow R; Von Baehr R
    Hybridoma; 1989 Oct; 8(5):529-33. PubMed ID: 2680900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies against tetanus toxin and toxoid.
    Ahnert-Hilger G; Bizzini B; Goretzki K; Müller H; Völckers C; Habermann E
    Med Microbiol Immunol; 1983; 172(2):123-35. PubMed ID: 6193402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of tetanus toxin and toxoid by ELISA using monoclonal antibodies].
    Burkin MA; Sviridov VV; Perelygina OV
    Prikl Biokhim Mikrobiol; 2004; 40(4):478-84. PubMed ID: 15455723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human hybridomas secreting antibody to tetanus toxoid.
    Larrick JW; Truitt KE; Raubitschek AA; Senyk G; Wang JC
    Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6376-80. PubMed ID: 6578513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.
    Kozbor D; Roder JC; Chang TH; Steplewski Z; Koprowski H
    Hybridoma; 1982; 1(3):323-8. PubMed ID: 6092264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human lymphoblastoid cell line producing protective monoclonal IgG1, kappa anti-tetanus toxin.
    Tiebout RF; Stricker EA; Hagenaars R; Zeijlemaker WP
    Eur J Immunol; 1984 May; 14(5):399-404. PubMed ID: 6327321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of a novel human monoclonal antibody that neutralizes tetanus toxin.
    Simpson LL; Lake P; Kozaki S
    J Pharmacol Exp Ther; 1990 Jul; 254(1):98-103. PubMed ID: 1694896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The selective role of membrane IgG in the antigen-induced inhibition of human in vitro antibody synthesis.
    Stevens RH; Benveniste E; Pineda E
    J Immunol; 1982 Jan; 128(1):398-401. PubMed ID: 6798112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective production of anti-tetanus toxoid and anti-HBsAg human monoclonal antibodies by serum-free culture of hybridomas.
    Kitano K; Ichimori Y; Sawada H; Iwasa S; Sasai S; Tsukamoto K
    Cytotechnology; 1991; 5 Suppl 2():S53-74. PubMed ID: 1367254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.